OTCMKTS:CRLBFCresco Labs Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cresco Labs Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.74 +0.19 (+4.18 %) (As of 05/22/2020 04:00 PM ET) Add Compare Share Today's Range$4.49Now: $4.74▼$4.8150-Day Range$2.63MA: $3.58▼$4.5552-Week Range$1.94Now: $4.74▼$11.99Volume633,942 shsAverage Volume634,855 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media Cresco Labs Inc. cultivates, manufactures, and sells medical cannabis and medical cannabis products in the United States. It offers cannabis in flower, vape pens, and various forms of extracts under the cresco and Reserve brands; precisely-dosed and non-combustible products, including tinctures, capsules, salves, sublingual oils, and transdermal patches under the Remedi brand; culinary-backed and cannabis-infused edibles under the Mindy's Artisanal brand; and fruity confections under the Mindy's Kitchen brand. As of June 12, 2019, it operated 20 dispensaries in Florida. The company is headquartered in Chicago, Illinois.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingCresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $11.30, Cresco Labs has a potential upside of 138.4% from its current price of $4.74.Amount of Analyst CoverageCresco Labs has only been the subject of 2 research reports in the past 90 days. Previous Next 2.8 Community Rank Outperform VotesCresco Labs has received 123 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCresco Labs has received 99 “underperform” votes. (Add your “underperform” vote.)Community SentimentCresco Labs has received 55.41% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cresco Labs and other stocks. Vote “Outperform” if you believe CRLBF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRLBF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.26 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CRLBF Previous Symbol CUSIPN/A CIKN/A Webwww.crescolabs.com Phone312-929-0993Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,400 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:CRLBF Rates by TradingView Receive CRLBF News and Ratings via Email Sign-up to receive the latest news and ratings for CRLBF and its competitors with MarketBeat's FREE daily newsletter. Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions How has Cresco Labs' stock been impacted by COVID-19 (Coronavirus)? Cresco Labs' stock was trading at $3.34 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CRLBF stock has increased by 41.9% and is now trading at $4.74. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Cresco Labs? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cresco Labs. What price target have analysts set for CRLBF? 7 equities research analysts have issued 1-year target prices for Cresco Labs' stock. Their forecasts range from $8.00 to $14.00. On average, they expect Cresco Labs' stock price to reach $11.30 in the next twelve months. This suggests a possible upside of 138.4% from the stock's current price. View analysts' price targets for Cresco Labs. Has Cresco Labs been receiving favorable news coverage? Media stories about CRLBF stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cresco Labs earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news aboutCresco Labs. Who are some of Cresco Labs' key competitors? Some companies that are related to Cresco Labs include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). View all competitors. Who are Cresco Labs' key executives? Cresco Labs' management team includes the following people: Mr. Charles Bachtell, Co-Founder, CEO & Director (Age 41)Mr. Brian Thomas McCormack, Co-Founder & Vice-Chairman (Age 51)Mr. Joseph Stevens Caltabiano, Pres, Co-founder & Director (Age 42)Mr. Dominic Anthony Sergi, Co-Founder & Director (Age 36)Mr. Robert M. Sampson, Co-Founder & Director (Age 45) What is Cresco Labs' stock symbol? Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF." How do I buy shares of Cresco Labs? Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Cresco Labs' stock price today? One share of CRLBF stock can currently be purchased for approximately $4.74. What is Cresco Labs' official website? The official website for Cresco Labs is www.crescolabs.com. How can I contact Cresco Labs? The company can be reached via phone at 312-929-0993. This page was last updated on 5/24/2020 by MarketBeat.com Staff
